1. Home
  2. CCO vs NVAX Comparison

CCO vs NVAX Comparison

Compare CCO & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clear Channel Outdoor Holdings Inc.

CCO

Clear Channel Outdoor Holdings Inc.

HOLD

Current Price

$2.40

Market Cap

1.2B

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$8.08

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCO
NVAX
Founded
1995
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
2005
1996

Fundamental Metrics

Financial Performance
Metric
CCO
NVAX
Price
$2.40
$8.08
Analyst Decision
Hold
Hold
Analyst Count
5
9
Target Price
$2.12
$11.33
AVG Volume (30 Days)
4.4M
2.7M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
110.81
309.76
EPS
0.04
2.58
Revenue
$1,604,140,000.00
$1,123,479,000.00
Revenue This Year
$5.35
N/A
Revenue Next Year
$4.26
N/A
P/E Ratio
$59.75
$3.12
Revenue Growth
6.57
64.69
52 Week Low
$1.00
$5.80
52 Week High
$2.43
$11.85

Technical Indicators

Market Signals
Indicator
CCO
NVAX
Relative Strength Index (RSI) 56.10 41.70
Support Level $2.37 $7.70
Resistance Level $2.41 $9.02
Average True Range (ATR) 0.01 0.29
MACD -0.00 0.01
Stochastic Oscillator 60.00 26.95

Price Performance

Historical Comparison
CCO
NVAX

About CCO Clear Channel Outdoor Holdings Inc.

Clear Channel Outdoor Holdings Inc is a provider of out-of-home advertising solutions. The company offers advertisers an opportunity to reach mass audiences across various high-traffic public spaces, by using its diverse portfolio of assets including roadside billboards, street furniture, and airport displays. Its reportable segments are; America (U.S. operations excluding airports), Airports (U.S. and Caribbean airport operations), and Other. A majority of its revenue is generated from the America segment which generates revenue from the sale of advertising on printed and digital out-of-home advertising displays such as bulletins, posters, street furniture, and others. Geographically, the company generates maximum revenue from the United States followed by Singapore.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: